Brendan O'sullivan

Birmingham, ENG B152GW, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Inter- and Intra-Observer Agreement of PD-L1 SP142 Scoring in Breast Carcinoma-A Large Multi-Institutional International Study.

Inter- and Intra-Observer Agreement of PD-L1 SP142 Scoring in Breast Carcinoma-A Large Multi-Institutional International Study.

Journal: Cancers

Published: November 01, 2022

Managing relapsed refractory lymphoma with palliative oral chemotherapy: A multicentre retrospective study.

Managing relapsed refractory lymphoma with palliative oral chemotherapy: A multicentre retrospective study.

Journal: EJHaem

Published: May 26, 2022

PD-L1 Testing in Urothelial Carcinoma: Analysis of a Series of 1401 Cases Using Both the 22C3 and SP142 Assays.

PD-L1 Testing in Urothelial Carcinoma: Analysis of a Series of 1401 Cases Using Both the 22C3 and SP142 Assays.

Journal: Pathology oncology research : POR

Published: December 14, 2021

Incidents in Molecular Pathology: Frequency and Causes During Routine Testing.

Incidents in Molecular Pathology: Frequency and Causes During Routine Testing.

Journal: Archives of pathology & laboratory medicine

Published: October 13, 2020

Predictive markers for anti-PD-1/PD-L1 therapy in non-small cell lung cancer-where are we?

Predictive markers for anti-PD-1/PD-L1 therapy in non-small cell lung cancer-where are we?

Journal: Translational lung cancer research

Published: December 04, 2018

The Clinicopathological and Molecular Associations of PD-L1 Expression in Non-small Cell Lung Cancer: Analysis of a Series of 10,005 Cases Tested with the 22C3 Assay.

The Clinicopathological and Molecular Associations of PD-L1 Expression in Non-small Cell Lung Cancer: Analysis of a Series of 10,005 Cases Tested with the 22C3 Assay.

Journal: Pathology oncology research : POR

Published: June 02, 2018

Large-Scale EGFR Mutation Testing in Clinical Practice: Analysis of a Series of 18,920 Non-Small Cell Lung Cancer Cases.

Large-Scale EGFR Mutation Testing in Clinical Practice: Analysis of a Series of 18,920 Non-Small Cell Lung Cancer Cases.

Journal: Pathology oncology research : POR

Published: December 17, 2017

Epidermal Growth Factor Receptor (EGFR) Kinase Inhibitors and Non-Small Cell Lung Cancer (NSCLC) - Advances in Molecular Diagnostic Techniques to Facilitate Targeted Therapy.

Epidermal Growth Factor Receptor (EGFR) Kinase Inhibitors and Non-Small Cell Lung Cancer (NSCLC) - Advances in Molecular Diagnostic Techniques to Facilitate Targeted Therapy.

Journal: Pathology oncology research : POR

Published: October 14, 2017

Tracking the Evolution of Non-Small-Cell Lung Cancer.

Tracking the Evolution of Non-Small-Cell Lung Cancer.

Journal: The New England journal of medicine

Published: April 27, 2017

Multi-Center Evaluation of the Fully Automated PCR-Based Idylla™ KRAS Mutation Assay for Rapid KRAS Mutation Status Determination on Formalin-Fixed Paraffin-Embedded Tissue of Human Colorectal Cancer.

Multi-Center Evaluation of the Fully Automated PCR-Based Idylla™ KRAS Mutation Assay for Rapid KRAS Mutation Status Determination on Formalin-Fixed Paraffin-Embedded Tissue of Human Colorectal Cancer.

Journal: PloS one

Published: June 13, 2016

Microscopic gastrointestinal stromal tumours: a clinical and molecular study of 13 cases.

Microscopic gastrointestinal stromal tumours: a clinical and molecular study of 13 cases.

Journal: Histopathology

Published: May 16, 2016

Genomic complexity of urothelial bladder cancer revealed in urinary cfDNA.

Genomic complexity of urothelial bladder cancer revealed in urinary cfDNA.

Journal: European journal of human genetics : EJHG

Published: June 02, 2015

Showing 1-12 of 16

Last Updated: 09/26/2026